Advisor Group Holdings, Inc. Silence Therapeutics PLC Transaction History
Advisor Group Holdings, Inc.
- $42.1 Billion
- Q1 2025
A detailed history of Advisor Group Holdings, Inc. transactions in Silence Therapeutics PLC stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 71,497 shares of SLN stock, worth $403,958. This represents 0.0% of its overall portfolio holdings.
Number of Shares
71,497
Previous 13,159
443.33%
Holding current value
$403,958
Previous $90,000
123.33%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding SLN
# of Institutions
61Shares Held
22.7MCall Options Held
1.3KPut Options Held
2.6K-
Tcg Crossover Management, LLC Palo Alto, CA3.03MShares$17.1 Million2.06% of portfolio
-
Siren, L.L.C. New York, NY2.79MShares$15.8 Million0.45% of portfolio
-
Redmile Group, LLC San Francisco, CA2.21MShares$12.5 Million0.66% of portfolio
-
Morgan Stanley New York, NY2MShares$11.3 Million0.0% of portfolio
-
Lombard Odier Asset Management (Usa) Corp New York, NY1.85MShares$10.5 Million0.44% of portfolio
About Silence Therapeutics plc
- Ticker SLN
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,888,400
- Market Cap $203M
- Description
- Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development of novel ribonucleic acid (RNA) therapeutics in hematology, cardiovascular, and other rare and metabolic indications. The company's platform includes mRNAi GalNAc Oligonucleotide Discovery platform designed to accurately target specific disease-associated...